Doctor: Risk Comparison Trials Should Pose Minimal Risk

Clinical Trials Advisor
The Office of Human Research Protections’ recent proposal to classify risk-comparison trials as “greater than minimal risk” will force physicians and patients to engage in overly burdensome informed consent processes that are out of proportion to the scope of the trials themselves, a leading bioethicist says.

To View This Article:


Subscribe To Clinical Trials Advisor